Novel approaches to the endocrine therapy of breast cancer

This publication has 24 references indexed in Scilit:

• Phase I/II study of the anti-oestrogen zindoxifene (D16726) in the treatment of advanced breast cancer. A Cancer Research Campaign Phase I/II Clinical Trials Committee study
  British Journal of Cancer, 1990
• A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer
  British Journal of Cancer, 1989
• Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells
  Journal of Molecular Endocrinology, 1989
• The development of tamoxifen for breast cancer therapy: A tribute to the late Arthur L. Walpole
  Breast Cancer Research and Treatment, 1988
• STEROIDAL PURE ANTIOESTROGENS
  Journal of Endocrinology, 1987
• A new triphenylethylene compound, Fc-1157a
  Cancer Chemotherapy and Pharmacology, 1986
• LOW-DOSE AMINOGLUTETHIMIDE IN TREATMENT OF ADVANCED BREAST CANCER
  The Lancet, 1984
• Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase
  Biochemical and Biophysical Research Communications, 1984
• Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*
  Journal of Clinical Endocrinology & Metabolism, 1978
• ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1
  The Lancet, 1896